FDA, CDC call for pause in use of Johnson & Johnson vaccine after six reported cases of rare blood clots newsindiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsindiatimes.com Daily Mail and Mail on Sunday newspapers.
By
Apr 13, 2021 09:29 AM EDT
The FDA and the CDC are requesting that the Johnson & Johnson vaccine be halted in the United States after six women developed rare blood clots and one died after receiving the vaccine.
FDA, CDC recommends pause on using J&J COVID-19 vaccine
(Photo : Michael M. Santiago/Getty Images)
Pop Up Vaccination Sites In NYC Spread To Neighborhoods Across The City NEW YORK, NEW YORK - APRIL 08: Johnson & Johnson coronavirus (COVID-19) vaccines are seen in a refrigerator at the Northwell Health pop-up coronavirus (COVID-19) vaccination site at the Albanian Islamic Cultural Center in Staten Island on April 08, 2021 in New York City. NYC continues to have a 6.55 percent coronavirus (COVID-19) cases on a seven-day rolling average as the city continues to ramp up vaccinations. The city last week set a record of 524,520 coronavirus (COVID-19) vaccinations.
Doses of the Johnson & Johnson COVID-19 vaccine will drop by 86% next week after one of the company s manufacturers released a stockpile and those have been distributed. (Michael M. Santiago/Getty Images)
There will be 86% fewer Johnson & Johnson vaccine doses allocated to states next week, new data from the Centers for Disease Control and Prevention show, highlighting the company s yo-yoing vaccine supply from week to week.
But next week s dip in supply isn t exactly the setback it appears to be.
It s the other side of a recent surge in Johnson & Johnson doses. The surge occurred because one of Johnson & Johnson s third party manufacturers was finally able to release its stockpile.
Why There Will Be Fewer Johnson & Johnson COVID-19 Vaccines Next Week
at 3:27 pm NPR
There will be 86% fewer Johnson & Johnson vaccine doses allocated to states next week, new data from the Centers for Disease Control and Prevention show, highlighting the company s yo-yoing vaccine supply from week to week.
But next week s dip in supply isn t exactly the setback it appears to be.
It s the other side of a recent surge in Johnson & Johnson doses. The surge occurred because one of Johnson & Johnson s third party manufacturers was finally able to release its stockpile.
The company is called Catalent, and its facility in Indiana had been working on filling vaccine vials and readying them for distribution for a while. But it only recently got the Food and Drug Administration s blessing, officially adding it to J&J s supply chain and allowing its doses to be released to the public.
Why There Will Be Fewer Johnson & Johnson COVID-19 Vaccines Next Week wsiu.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wsiu.org Daily Mail and Mail on Sunday newspapers.